603883.SH
LBX Pharmacy Chain JSC
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 14.52
−2.35%Oct 26, 2026, 09:26 UTC
Laobaixing Pharmacy Chain Joint Stock Company reported third-quarter 2026 revenue of CNY 5.653 billion, net profit attributable to shareholders of CNY 171 million, and adjusted net profit of CNY 168 million; for the first nine months, it reported revenue of CNY 16.65 billion, net profit of CNY 618 million, and adjusted net profit of CNY 604 million.
Source:Oct 16, 2026, 09:13 UTC
Laobaixing Pharmaceutical reported that it had cumulatively repurchased 3.9399 million shares, or 0.52% of its total share capital, for 51.734 million yuan.
Source:Sep 2, 2026, 07:43 UTC
Laobaixing announced a share buyback plan of 40 million to 80 million yuan.
Source:Aug 27, 2026, 09:59 UTC
Laobaixing announced a cash dividend of 0.3 yuan per share (including tax), totaling 228 million yuan (including tax).
Aug 27, 2026, 09:59 UTC
Laobaixing announced its first-half 2026 results: revenue of 10.998 billion yuan, up 2.07% year-on-year; net profit attributable to shareholders of 447 million yuan, up 12.30% year-on-year; non-recurring net profit of 436 million yuan, up 14.48% year-on-year.